Over-the-counter Narcan hitting shelves in September
Emergent’s name-brand Narcan was FDA-approved in March, and was the first-ever naloxone product to be approved for use without a prescription in the U.S.
Stay updated with breaking news from Emergent Biosolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emergent’s name-brand Narcan was FDA-approved in March, and was the first-ever naloxone product to be approved for use without a prescription in the U.S.
WEDNESDAY, Aug. 30, 2023 (HealthDay News) -- Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.
Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.
Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week.
Hepion Pharmaceuticals (NASDAQ:HEPA – Get Free Report) and Emergent BioSolutions (NYSE:EBS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk. Analyst Recommendations This is a summary of […]